Vakiener Victoria
SEC CIK 1826263 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Dir | 37.7K | — | $1.14M | 10 | 2023-01-10 | 2025-12-19 |
Most active insiders at ARWR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Anzalone Christopher Richard | CEO, Dir | — | $24.01M |
| 2 | Hamilton James C | Chief Medical Off | — | $4.63M |
| 3 | O'Brien Patrick | COO | — | $3.12M |
| 4 | PERRY MICHAEL S | Dir | — | $2.00M |
| 5 | Ferrari Mauro | Dir | — | $1.02M |
| 6 | Apel Daniel Joseph | CFO | — | $934.3K |
| 7 | OLUKOTUN ADEOYE Y | Dir | — | $850.5K |
| 8 | Vakiener Victoria | Dir | — | $679.5K |
| 9 | Waddill William D. | Dir | — | $566.0K |
| 10 | Lu Hongbo | Dir | — | $228.3K |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-12-23 | 2025-12-19 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Dir | S - Sale | $67.68 | -10.0K | 37.7K | -21% | -$679.5K |
| 2025-12-18 | 2025-12-16 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Dir | A - Grant | $0.00 | +7,819 | 45.8K | +21% | $0 | |
| 2024-12-20 | 2024-12-18 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Dir | A - Grant | $22.99 | +16.7K | 37.9K | +79% | +$384.7K | |
| 2024-12-18 | 2024-12-16 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Dir | S - Sale | $21.91 | -8,994 | 21.2K | -30% | -$197.1K | |
| 2024-05-06 | 2024-05-02 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Dir | S - Sale | $23.31 | -1,799 | 30.2K | -6% | -$41.9K | |
| M | 2024-01-16 | 2024-01-11 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Dir | S - Sale | $38.10 | -4,720 | 32.0K | -13% | -$179.8K |
| 2023-12-19 | 2023-12-15 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Dir | A - Grant | $25.41 | +15.0K | 36.7K | +69% | +$380.8K | |
| 2023-10-02 | 2023-09-28 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Dir | S - Sale | $26.33 | -1,550 | 21.7K | -7% | -$40.8K | |
| D | 2023-01-11 | 2023-01-10 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Dir | A - Grant | $0.00 | +7,867 | 23.3K | +51% | $0 |
| D | 2023-01-11 | 2023-01-10 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Dir | D - Sale to Iss | $0.00 | -1,764 | 15.4K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations